期刊文献+

单抗制品中CHO细胞宿主蛋白残留双抗夹心ELISA检测方法的建立 被引量:5

Development of a double antibody sandwich ELISA for detection of residual host cell protein of CHO cells in monoclonal antibody products
原文传递
导出
摘要 目的建立单抗制品中CHO细胞宿主蛋白(host cell protein,HCP)残留双抗夹心ELISA检测方法。方法确定双抗夹心ELISA方法的最佳工作条件,并对该方法的精密度和准确度进行验证,确定线性范围及最低检出限;用建立的方法与市售试剂盒分别检测低、中、高浓度HCP标准品及抗TNF-α单抗原液、抗VEGF单抗纯化工艺样品中的HCP。结果建立的双抗夹心ELISA法最佳抗体包被浓度为1.5μg/ml,酶标抗体浓度为1μg/ml,160 r/min,37℃孵育2.5 h;TMB 37℃孵育15 min;以630 nm为参比波长,450 nm为测定波长。该方法的线性范围为3.125~100 ng/ml,最低检测限为3.125 ng/ml;试验内变异系数(CV)和试验间CV均小于15%,回收率为85.3%~115.1%。与商品化试剂盒检测结果基本一致,可用于检测纯化工艺样品。结论已成功建立单抗制品中CHO细胞HCP残留双抗夹心ELISA检测方法,该方法可代替市售试剂盒用于CHO细胞HCP残留检测,可使检测成本降低30倍。 Objective To develop a double antibody sandwich ELISA method for detection of residual host cell protein(HCP)of CHO cells in monoclonal antibody(Mc Ab)products. Methods The working condition for double antibody sandwich ELISA was optimized, and the developed method was verified for precision and accuracy and determined for lin-ear range and minimum detection limit. The standard HCPs at low, moderate and high concentrations as well as HCPs in bulk of Mc Ab against TNF-α and purification process sample of Mc Ab against VEGF were determined by the developed method, using the commercial kit as control. Results The optimal working concentrations of coating and enzyme-labeled antibodies were 1. 5 and 1. 0 μg / ml respectively. The samples and enzyme-labeled antibody were added simultaneously and oscillated at 160 r / min, and incubated at 37 ℃ for 2. 5 h, then added with substance TMB and incubated at 37 ℃for 15 min. The reference and detection wavelengths were 630 and 450 nm respectively. The linear range of developed method was 3. 125 ~ 100 ng / ml, while the minimum detection limit was 3. 125 ng / ml. Both the CVs in intra- and interassays were less than 15%, while the recovery rate was 85. 3% ~ 115. 1%. The determination results by the developed method was basically consistent with that by commercial kit, indicating that the method might be used for determination of purification process samples. Conclusion A double antibody sandwich ELISA method for detection of HCP of CHO cells in Mc Ab products instead of commercial kit was successfully developed, of which the cost decreased by 30 folds.
出处 《中国生物制品学杂志》 CAS CSCD 2015年第8期837-840,共4页 Chinese Journal of Biologicals
基金 广东省引进创新科研团队计划项目(201101Y0104990178)
关键词 CHO细胞 宿主蛋白 双抗夹心酶联免疫吸附法 CHO cells Host cell protein(HCP) Double antibody sandwich ELISA
  • 相关文献

参考文献12

  • 1Hogwood CE, Bracewell DG, Smales CM. Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses [J]. Curr Opin Biotechnol, 2014, 30 ( 1 ): 153-160.
  • 2Meleady P, Doolan P, Henry M, et al. Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotype [ J 1. BMC Biotechnol, 2011, 11 ( 1 ) : 78-88 .
  • 3Marichal-Gallardo PA, Alvarez MM. State-of-the-art in down- stream processing of monoclonal antibodies: process trends in design and validation [J]. Biotechnol Prog, 2012, 28 (4): 899-916.
  • 4Chon JH, Zarbis-Papastoitsis G. Advances in the production and downstream processing of antibodies [J]. N Biotechnol, 2011, 28 (5): 458-463.
  • 5Hogwood CE, Tait AS, Koloteva-Levine N, et al. The dyna- mics of the CHO host cell protein profile during clarification and protein A capture in a platform antibody purification pro- cess [ J ]. Biotechnol Bioeng, 2013, 110 ( 1 ) : 240-251.
  • 6Capito F, Skudas R, Kolmar H, et al. Host cell protein quantification by Fourier transform mid infrared spectroscopy (FT-MIR)[Z]. Biotechnol Bioeng, 2013, 110 ( 1 ): 252-259.
  • 7Gjoka X, Schofield M, Cvetkovic A, et al. Combined protein A and size exclusion high performance liquid chromatography for the single-step measurement of mAb, aggregates and host cell proteins [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2014, 972 (1) : 48-52.
  • 8Rey G, Wendeler MW. Full automation and validation of a flexible ELISA platform for host cell protein and protein A impurity detection in biopharmaceuticals [J]. J Pharm Biomed Anal, 2012, 70 (11): 580-586.
  • 9Wang X, Hunter AK, Mozier NM. Host cell proteins in biologics development: identification, quantitation and risk assessment [J]. Biotechnol Bioeug, 2009, 103 (3): 446-458.
  • 10潘殊男,肖詹蓉,王宇星,张霖阳,史雨舟,孙芳芳,张萍.脑膜炎球菌W135群多糖含量和分子大小双抗体夹心ELISA检测方法的建立及初步应用[J].中国生物制品学杂志,2012,25(12):1688-1691. 被引量:1

二级参考文献16

  • 1Wilder-Smith A, Barkham TM, Earnest A, et al. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study [J]. BMJ, 2002, 325 (7360) : 365-366.
  • 2Bardotti A, Averani G, Berti F, et al. Physicochemical charac- tefisation of glycoconjugate vaccines for prevention of meningo- coccal diseases [J]. Vaccine, 2008, 26 (18) : 2284-2296.
  • 3Pace D, Pollard A J, Messonier NE. Quadrivalent meningococcal conjugate vaccines [J]. Vaccine, 2009, 27 (Suppl 2): B30-B41.
  • 4Snape MD, Perrett KP, Ford KJ, et al. Immunogenicity of a te- travalent meningococcal glycoconjugate vaccine in infants: a ran- domized controlled trial [J]. JAMA, 2008, 299 (2): 173-184.
  • 5Pace D, Pollard AJ. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines [J]. Arch Dis Child, 2007, 92 (10): 909-915.
  • 6Miller E, Pollard A, Findlow J, et al. Safety and immunogenici- ty of Novartis meningococcal serogroup B vaccine (MenB vaccine) after three doses administered in infancy [R] // 26 th Annual Meeting of the European Society for Paediatric Infectious Disease. Austria: Graz, 2008.
  • 7WHO Progress Report 2002 Global defence against the infectious disease threat Report 2002 [ OL]. http:/! www.who.int/infectious- disease-news ! cds2002 ! en/.
  • 8Kirnbauer R,Booy F,Cheng N,et al.Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic[J].Proc Natl Acad Sci USA,1992,89(24):12180-12184.
  • 9Small EJ,Fratesi P,Reese DM,et al.Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells[J].J Clin Oncol,2000,18(23):3894-3903.
  • 10Cox MM,Hashimoto Y.A fast track influenza virus vaccine produced in insect cells[J].J Invertebr Pathol,2011,107(Suppl):S31-S41.

共引文献41

同被引文献20

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部